CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients

In gastric cancer (GC), biomarkers that define prognosis and predict treatment response remain scarce. We hypothesized that the extent of CD44v6 membranous tumor expression could predict prognosis and therapy response in GC patients. Two GC surgical cohorts, from Portugal and South Korea (n = 964),...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Gabriela M, Pereira, Carla, Park, Ji-Hyeon, Lemos, Carolina, Campelos, Sofia, Gullo, Irene, Martins, Diana, Gonçalves, Gilza, Leitão, Dina, Neto, João Luís, André, Ana, Borges, Clara, Almeida, Daniela, Lee, Hyuk-Joon, Kong, Seong-Ho, Kim, Woo Ho, Carneiro, Fátima, Almeida, Raquel, Yang, Han-Kwang, Oliveira, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465138/
https://www.ncbi.nlm.nih.gov/pubmed/34572441
http://dx.doi.org/10.3390/biomedicines9091249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465138/
https://www.ncbi.nlm.nih.gov/pubmed/34572441
http://dx.doi.org/10.3390/biomedicines9091249

Ejemplares similares